Ravi Majeti MD, PhD

Ravi Majeti MD, PhD

Hematologist

Bio:   Dr. Ravi Majeti is an Associate Professor in the Department of Medicine, Chief of the Division of Hematology, and Member of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University. He was an undergraduate at Harvard, earned his MD and PhD from UCSF, and trained in Internal Medicine at Brigham and Women’s Hospital in Boston. Dr. Majeti completed his Hematology Fellowship at Stanford, and is a board-certified hematologist. While at Stanford, he completed post-doctoral training in the laboratory of Irving Weissman, where he investigated acute myeloid leukemia (AML) stem cells and therapeutic targeting with anti-CD47 antibodies. With Dr. Weissman, he developed a humanized anti-CD47 antibody, initiated first-in-human clinical trials, and in 2015, co-founded Forty Seven Inc. Dr. Majeti established his independent laboratory in 2009 with research focused on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly AML. Dr. Majeti is a recipient of the Burroughs Wellcome Fund Career Award for Medical Scientists, the New York Stem Cell Foundation Robertson Investigator Award, and the Leukemia and Lymphoma Society Scholar Award.

Stanford Cancer Center Palo Alto

Professional Education

  • Board Certification: Hematology, American Board of Internal Medicine (2007)
  • Residency: Brigham and Women's Hospital Harvard Medical School (2004) MA
  • Fellowship: Stanford University Medical Center (2008) CA
  • Medical Education: University of California at San Francisco School of Medicine (2002) CA

Honors & Awards

  • Career Award for Medical Scientists, Burroughs Wellcome Fund (2008)
  • Robertson Investigator Award, New York Stem Cell Foundation (2011)
  • Scholar Award, Leukemia and Lymphoma Society (2015)

Administrative Appointments

  • Assistant Director, Stanford Ludwig Center for Cancer Stem Cell Research (2014 - Present)
  • Chief, Division of Hematology (2017 - Present)
  • Co-Director, Translational Research Program - Internal Medicine Residency (2013 - 2017)
  • Co-Director, Lymphoma and Leukemia Program - Stanford Cancer Institute (2014 - Present)